NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Children's Health (https://www.neurotalk.org/children-s-health/)
-   -   Feds Approve Drug to Treat Symptoms of Autism (https://www.neurotalk.org/children-s-health/3069-feds-approve-drug-treat-symptoms-autism.html)

GinaMarie 10-07-2006 12:23 AM

Feds Approve Drug to Treat Symptoms of Autism
 
http://cbs13.com/health/local_story_279183526.html

Oct 6, 2006 3:33 pm US/Pacific

Feds Approve Drug To Treat Symptoms Of Autism

(AP) WASHINGTON A Johnson & Johnson drug received expanded federal approval Friday to treat aggression and other symptoms of autism in children.

The new use for Risperdal is to treat irritability associated with autistic disorder, including temper tantrums, deliberate self-injury and aggression in children and adolescents, ages 5 to 16.

The approval is the first for the use of a drug to treat behaviors associated with autism in children, the Food and Drug Administration said.

Risperdal, first approved by the FDA in 1993, has been used to treat schizophrenia and bipolar disorder in adults.

The antipsychotic drug is not a cure for autism, nor does it treat the condition itself, but it may provide relief for some children, according to Johnson & Johnson.

Autism is a complex developmental disability. It typically appears during a child's first three years of life, and it affects communication, social interaction and creative or imaginative play.

In 2005, the FDA declined to expand its approval of Risperdal, also known as risperidone, to include autism.

The most common side effects of Risperdal include drowsiness, constipation, fatigue and weight gain.


(© 2006 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)


All times are GMT -5. The time now is 03:39 AM.

Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.